drugset / Trial / NCT01286090

An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus

NCT01286090 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the effectiveness of cisapride at improving symptoms associated with gastroparesis (a stomach disorder) in patients with diabetes mellitus.

Timeline

Start
2003-07
Primary completion
—
Completion
2003-10

Outcome

Outcome not reported

Stopped: “Sponsor request”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisapride Small molecule 10 mg Oral